Falchi Lorenzo and Nijland Marcel and Huang Huiqiang and Linton Kim M and Seymour John F and Tao Rong and Kwiatek Michal and Costa Abel and Vassilakopoulos Theodoros P and Greil Richard and Jiménez-Ubieto Ana and Gangatharan Shane A and Benjamini Ohad and Thieblemont Catherine and Tucci Alessandra and Elinder-Camburn Anna and Illes Arpad and Novak Jan and Pavlovsky Miguel A and McDonald Andrew and Yoon Dok Hyun and Maruyama Dai and Sunkersett Gauri and Mei Jian P and Mukherjee Nabanita and Zhu Feng and Alshreef Abualbishr and Favaro Elena and Morschhauser Franck and Kollaborációs szervezet: EPCORE FL-1 Investigators and Modok Szabolcs and Mikala Gábor and Masszi András and Rajnics Péter and et al.:
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1) : a global, open-label, randomised, phase 3 trial.
LANCET, 407 (10524).
pp. 161-173.
ISSN 0140-6736
(2026)